Thermo Fisher Scientific, Inc. Share Price

"The Company was the product of a merger between parent companies Thermo Electron & Fisher Scientific in 2006. Among Thermo Electron's product offerings were analytical and laboratory instruments. Its revenues in 2004 totalled $2 billion. Fisher Scientific was founded in 1902. It provides laboratory equipment and associated services. The resultant Company is in the healthcare industry, specialising in diagnostic and research. The Company's segments are life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services. Over the years, 65 companies were acquired by Thermo Fisher Scientific, including 13 in just the past five years. Private equity firms funded approximately 22 acquisitions. Additionally, eight assets were divested. A $17.4 billion acquisition in 2021 was Thermo Fisher Scientific's largest acquisition to date. The most recent acquisitions are Mesa Biotech and the European Viral Vector business. Currently, the Company has more than 4,00,000 customers around the world. It has employed over 75,000 people. North America accounts for more than half of the Company's sales. The Company's core markets are pharmaceuticals, biotechs, diagnostics, health care, academics, and government. It stands in line with companies such as Abbott Laboratories, Becton Dickinson & Agilent Technologies. Currently Thermo Fisher Scientific, Inc. has a market cap of $235.43 Billion. It has a P.E ratio of 36.24. The shares of Thermo Fisher Scientific, Inc. are trading at {current share price in dollars (in INR)}."